Recapture and Retreatment Rates With Ixekizumab After Withdrawal of Therapy in Patients With Axial Spondyloarthritis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study
Ann. Rheum. Dis 2022 Sep 13;[EPub Ahead of Print], RBM Landewé, D Poddubnyy, P Rahman, FE Van den Bosch, R Bolce, S Liu Leage, JR Lisse, SY Park, L GenslerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.